Recent developments in the immunopathology of COVID‐19
There has been an important change in the clinical characteristics and immune profile of
Coronavirus disease 2019 (COVID‐19) patients during the pandemic thanks to the …
Coronavirus disease 2019 (COVID‐19) patients during the pandemic thanks to the …
Immunology of COVID‐19: mechanisms, clinical outcome, diagnostics, and perspectives—a report of the European Academy of Allergy and Clinical Immunology …
With the worldwide spread of the novel severe acute respiratory syndrome coronavirus‐2
(SARS‐CoV‐2) resulting in declaration of a pandemic by the World Health Organization …
(SARS‐CoV‐2) resulting in declaration of a pandemic by the World Health Organization …
A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2
Abstract In December 2019, China reported the first cases of the coronavirus disease 2019
(COVID‐19). This disease, caused by the severe acute respiratory syndrome–related …
(COVID‐19). This disease, caused by the severe acute respiratory syndrome–related …
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines
The first approved COVID‐19 vaccines include Pfizer/BioNTech BNT162B2, Moderna
mRNA‐1273 and AstraZeneca recombinant adenoviral ChAdOx1‐S. Soon after approval …
mRNA‐1273 and AstraZeneca recombinant adenoviral ChAdOx1‐S. Soon after approval …
[HTML][HTML] Severe allergic reactions to the COVID-19 vaccine–statement and practical consequences
J Kleine-Tebbe, L Klimek, E Hamelmann… - Allergologie …, 2021 - ncbi.nlm.nih.gov
On December 10, 2020, the BBC reported two allergic adverse events following the first
injection of the BioNTech COVID-19 vaccine BNT162b2. Up to December 19, 2020, severe …
injection of the BioNTech COVID-19 vaccine BNT162b2. Up to December 19, 2020, severe …
SARS-CoV-2 vaccines: where are we now?
The best and safest way to control the coronavirus disease 2019 (COVID-19) pandemic is by
using vaccination to generate widespread immunity. The urgent need to develop safe and …
using vaccination to generate widespread immunity. The urgent need to develop safe and …
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
As a zoonotic disease that has already spread globally to several million human beings and
possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID‐19) …
possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID‐19) …
Adverse reactions to COVID‐19 vaccines: a practical approach
K Rutkowski, R Mirakian, S Till… - Clinical & …, 2021 - Wiley Online Library
COVID‐19‐related mortality in high‐risk individuals is substantial and current treatment
options are limited. There is convincing evidence that the COVID‐19 vaccines reduce the …
options are limited. There is convincing evidence that the COVID‐19 vaccines reduce the …
Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI
L Klimek, KC Bergmann, R Brehler, W Pfützner… - Allergo journal …, 2021 - Springer
Background For the preventive treatment of the 2019 coronavirus disease (COVID-19) an
unprecedented global research effort studied the safety and efficacy of new vaccine …
unprecedented global research effort studied the safety and efficacy of new vaccine …
[HTML][HTML] COVID-19 vaccine-associated anaphylaxis: a statement of the World Allergy Organization Anaphylaxis Committee
PJ Turner, IJ Ansotegui, DE Campbell… - World Allergy …, 2021 - Elsevier
Vaccines against COVID-19 (and its emerging variants) are an essential global intervention
to control the current pandemic situation. Vaccines often cause adverse events; however …
to control the current pandemic situation. Vaccines often cause adverse events; however …